Lombardi Ronald M.

PBH CEO Ronald M. Lombardi sold 10,875 shares for $898,240.83 on Nov 19; stock at 52-week high.

CEO Ronald M. Lombardi executed 2 separate sales totaling 10,875 shares for $898,240.83 on 2024-11-19 at an average price of $82.60, reducing his holdings by 3.3% to 321.0K shares. The sales occurred as PBH trades at $84.14, its 52-week high, following a +17.3% surge over the past 30 and 90 days. Lombardi's cross-ticker track record shows a 100.00% well-timed rate on 6 prior sells with a -10.2% average 90-day return, while his same-ticker history at PBH (3 measurable prior sales in 2023) was similarly well-timed, with negative 90-day returns of -8.1%, -9.6%, and -10.9%. The filing warrants tracking of forward returns to evaluate whether this sale at the 52-week high aligns with Lombardi's demonstrated pattern of selling before subsequent declines.

CEO Ronald M. Lombardi sells 82,237 shares of PBH for $6.8M at blended average $82.56, reducing holdings by 20.4%

Ronald M. Lombardi, Chief Executive Officer of Prestige Consumer Healthcare Inc., executed 2 separate sales totaling 82,237 shares for $6,789,764.29 on 2024-11-18, with transaction prices of $82.67 and $82.41 respectively. His post-transaction holdings of 320,952 shares represent a 20.4% reduction from pre-transaction holdings of 403,189 shares. The stock is currently trading at $82.46, only 0.4% below its 52-week high of $82.79, following a +13.7% gain over the past 30 days and +17.6% over 90 days. His prior sells at PBH (3 trades in August 2023) were all well-timed, with negative 90-day returns ranging from -8.1% to -10.9%, establishing a 100% timing pattern at this ticker.